0000000000374273

AUTHOR

Dian-jeng Li

0000-0002-6036-045x

showing 2 related works from this author

Efficacy, safety and tolerability of aripiprazole in bipolar disorder: An updated systematic review and meta-analysis of randomized controlled trials

2017

Numerous studies have investigated aripiprazole as a treatment for bipolar disorder (BD). therefore we conducted this comprehensive meta-analysis to investigate the efficacy and safety profile of aripiprazole in treating BD. Two authors conducted systematic searches of PubMed and ScienceDirect from inception until May 14th, 2017. Randomized controlled trials (RCTs) of people with BD who received aripiprazole were included. A total of 20 RCTs met the eligibility criteria, including two which investigated the efficacy of aripiprazole versus haloperidol (aripiprazole = 340; haloperidol = 337), three which compared aripiprazole versus lithium (aripiprazole = 208; lithium = 212), and 15 with mul…

Transtorno Bipolarmedicine.medical_specialtyEfficacyBipolar disorderAripiprazolePlacebolaw.invention03 medical and health sciences0302 clinical medicineMaintenance therapyRandomized controlled trialAripiprazole; Bipolar disorder; Efficacy; Meta-analysis; Tolerability; Pharmacology; Biological PsychiatrylawInternal medicinemedicineHaloperidolHumansMeta-analysiBipolar disorderPsychiatryBiological PsychiatryRandomized Controlled Trials as TopicAripiprazole Bipolar disorder Efficacy Tolerability Meta-analysisPharmacologymedicine.diseaseTolerability030227 psychiatryMeta-analysisAripiprazolTolerabilityMeta-analysisAripiprazolePsychology030217 neurology & neurosurgeryAntipsychotic Agentsmedicine.drug
researchProduct

Use of statins and the risk of dementia and mild cognitive impairment: a systematic review and meta-analysis

2018

AbstractWe conducted a systematic review and meta-analysis to investigate whether the use of statins could be associated with the risk of all-caused dementia, Alzheimer’s disease (AD), vascular dementia (VaD), and mild cognitive impairment (MCI). Major electronic databases were searched until December 27th, 2017 for studies investigating use of statins and incident cognitive decline in adults. Random-effects meta-analyses calculating relative risks (RRs) were conducted to synthesize effect sizes of individual studies. Twenty-five studies met eligibility criteria. Use of statins was significantly associated with a reduced risk of all-caused dementia (k = 16 studies, adjusted RR (aRR) = 0.849…

medicine.medical_specialtylcsh:MedicineSubgroup analysisRisk AssessmentArticle03 medical and health sciences0302 clinical medicinemild cognitive impairmentInternal medicineMedicineDementiaHumansCognitive Dysfunction030212 general & internal medicineCognitive declineProspective cohort studyVascular dementialcsh:ScienceMultidisciplinarybusiness.industrylcsh:RStatinInibidores de Hidroximetilglutaril-CoA Redutasesmedicine.diseaseRelative riskMeta-analysislcsh:QDementiaHydroxymethylglutaryl-CoA Reductase InhibitorsbusinessRisk assessment030217 neurology & neurosurgerydementiaDemência
researchProduct